Comparison between single and combined post-treatment with S-Methyl-N,N-diethylthiolcarbamate sulfoxide and taurine following transient focal cerebral ischemia in rat brain

Neuroscience

Volumn 300, Issue , 2015, Pages 460-473

  Gharibani, P ^a,d   Modi, J ^a,b   Menzie, J ^a   Alexandrescu, A ^a   Ma, Z ^a   Tao, R ^a,b   Prentice, H ^a,b   Wu, J Y ^a,b,c  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Johns Hopkins University   (United States)

Author keywords

Apoptosis; DETC MeSO; Endoplasmic reticulum stress; Stroke; Taurine

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ACTIVATING TRANSCRIPTION FACTOR 6; CARBAMIC ACID DERIVATIVE; CASPASE 12; CASPASE 3; CYTOCHROME C; GLUCOSE REGULATED PROTEIN 78; INOSITOL REQUIRING ENZYME 1; MEMBRANE PROTEIN; PROTEIN BAX; S METHYL N,N DIETHYLTHIOLCARBAMATE SULFOXIDE; TAURINE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; DIETHYLDITHIOCARBAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; S-METHYL N,N-DIETHYLTHIOLCARBAMATE SULFOXIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; CELL FRACTIONATION; CELL SURVIVAL; CONTROLLED STUDY; DENSITOMETRY; ENDOPLASMIC RETICULUM STRESS; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RADIOIMMUNOPRECIPITATION; RAT; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; COMPARATIVE STUDY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; GLIOSIS; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; RANDOMIZATION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DITIOCARB; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; GLIOSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TAURINE; TREATMENT OUTCOME;

EID: 84936068316     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.042     Document Type: Article

References (78)

1. Adachi Y., Yamamoto K., Okada T., Yoshida H., Harada A., Mori K. ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct 2008, 33:75-89.
2. Ashwal S., Tone B., Tian H.R., Cole D.J., Pearce W.J. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 1998, 29:1037-1046. [discussion 1047].
3. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
4. Birdsall T.C. Therapeutic applications of taurine. Altern Med Rev 1998, 3:128-136.
5. Branchey L., Davis W., Lee K.K., Fuller R.K. Psychiatric complications of disulfiram treatment. Am J Psychiatry 1987, 144:1310-1312.
6. Chen X., Shen J., Prywes R. The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J Biol Chem 2002, 277:13045-13052.
7. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275:661-665.
8. Eberle J., Kurbanov B.M., Hossini A.M., Trefzer U., Fecker L.F. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Drug Resist Updat 2007, 10:218-234.
9. El Idrissi A., Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 1999, 19:9459-9468.
10. Foos T.M., Wu J.-Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 2002, 27:21-26.
11. George S., Kadam S.D., Irving N.D., Markowitz G.J., Raja S., Kwan A., Tu Y., Chen H., Rohde C., Smith D.R., Comi A.M. Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice. Front Cell Neurosci 2013, 7:123-130.
12. Gharibani P.M., Modi J., Pan C., Menzie J., Ma Z., Chen P.-C., Tao R., Prentice H., Wu J.-Y. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. Adv Exp Med Biol 2013, 776:241-258.
13. Go A.S., et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014, 129. e28-e292.
14. Gozlan H., Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection?. Trends Pharmacol Sci 1995, 16:368-374.
15. Guan W., Zhao Y., Xu C. A combined treatment with taurine and intra-arterial thrombolysis in an embolic model of stroke in rats: increased neuroprotective efficacy and extended therapeutic time window. Transl Stroke Res 2011, 2:80-91.
16. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
17. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000, 5:897-904.
18. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003, 11:619-633.
19. Hart B.W., Faiman M.D. In vivo pharmacodynamic studies of the disulfiram metabolite S-methyl N,N-diethylthiolcarbamate sulfoxide: inhibition of liver aldehyde dehydrogenase. Alcohol Clin Exp Res 1994, 18:340-345.
20. Hasegawa Y., Morioka M., Hasegawa S., Matsumoto J., Kawano T., Kai Y., Yano S., Fukunaga K., Kuratsu J.-I. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats. J Pharmacol Exp Ther 2006, 317:875-881.
21. Herculano-Houzel S., Lent R. Isotropic fractionator: a simple, rapid method for the quantification of total cell and neuron numbers in the brain. J Neurosci 2005, 25:2518-2521.
22. Huxtable R.J. Physiological actions of taurine. Physiol Rev 1992, 72:101-163.
23. Jin L., Davis M.R., Hu P., Baillie T.A. Identification of novel glutathione conjugates of disulfiram and diethyldithiocarbamate in rat bile by liquid chromatography-tandem mass spectrometry. Evidence for metabolic activation of disulfiram in vivo. Chem Res Toxicol 1994, 7:526-533.
24. Kiewert C., Mdzinarishvili A., Hartmann J., Bickel U., Klein J. Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in mice. Brain Res 2010, 1312:101-107.
25. Kilic E., Kilic U., Soliz J., Bassetti C.L., Gassmann M., Hermann D.M. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005, 19:2026-2028.
26. Kim I., Xu W., Reed J.C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008, 7:1013-1030.
27. Kramer M., Dang J., Baertling F., Denecke B., Clarner T., Kirsch C., Beyer C., Kipp M. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 2010, 187:84-89.
28. Kumar R., Azam S., Sullivan J.M., Owen C., Cavener D.R., Zhang P., Ron D., Harding H.P., Chen J.J., Han A., White B.C., Krause G.S., DeGracia D.J. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK. J Neurochem 2001, 77:1418-1421.
29. Lai E., Teodoro T., Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda) 2007, 22:193-201.
30. Lee A.-H., Iwakoshi N.N., Glimcher L.H. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003, 23:7448-7459.
31. Li F., Omae T., Fisher M., Dietrich W.D., Kuluz J.W. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats editorial comment. Stroke 1999, 30:2464-2471.
32. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., Gao Q., Shen L.H., Zhang J., Lu M., Chopp M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49:407-417.
33. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
34. Louzada P.R. Taurine prevents the neurotoxicity of -amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 2004, 18:511-518.
35. Matsumoto M., Minami M., Takeda K., Sakao Y., Akira S. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett 1996, 395:143-147.
36. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106. [discussion 106-107].
37. Minnerup J., Wersching H., Ringelstein E.B., Schilling M., Schäbitz W.-R., Wellmann J., Berger K. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Stroke 2011, 42:2838-2843.
38. Modi J.P., Gharibani P.M., Ma Z., Tao R., Menzie J., Prentice H., Wu J.-Y. Protective mechanism of sulindac in an animal model of ischemic stroke. Brain Res 2014, 12:91-99.
39. Mohammad-Gharibani P., Modi J., Menzie J., Genova R., Ma Z., Tao R., Prentice H., Wu J.-Y. Mode of action of S-methyl-N,N-diethylthiocarbamate Sulfoxide (DETC-MeSO) as a novel therapy for stroke in a rat model. Mol Neurobiol 2014, 50:655-672.
40. Morishima N., Nakanishi K., Nakano A. Activating transcription factor-6 (ATF6) mediates apoptosis with reduction of myeloid cell leukemia sequence 1 (Mcl-1) protein via induction of WW domain binding protein 1. J Biol Chem 2011, 286:35227-35235.
41. Nagendra S.N. Carbamoylation of brain glutamate receptors by a disulfiram metabolite. J Biol Chem 1997, 272:24247-24251.
42. Nagendra S.N., Faiman M.D., Davis K., Wu J.Y., Newby X., Schloss J.V. Carbamoylation of brain glutamate receptors by a disulfiram metabolite. J Biol Chem 1997, 272:24247-24251.
43. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000, 150:887-894.
44. Ni M., Zhang Y., Lee A.S. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J 2011, 434:181-188.
45. Ningaraj N.S., Chen W., Schloss J.V., Faiman M.D., Wu J.-Y. S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-d-aspartate receptor-mediated neurotoxicity. J Biomed Sci 2001, 8:104-113.
46. O'Donnell M.E., Lam T.I., Tran L.Q., Foroutan S., Anderson S.E. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 2006, 26:1234-1249.
47. Ouyang Y.-B., Lu Y., Yue S., Xu L.-J., Xiong X.-X., White R.E., Sun X., Giffard R.G. MiR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol Dis 2012, 45:555-563.
48. Pan C., Giraldo G.S., Prentice H., Wu J.-Y. Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress. J Biomed Sci 2010, 17(Suppl 1):S17.
49. Pan C., Prentice H., Price A.L., Wu J.-Y. Beneficial effect of taurine on hypoxia- and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture. Amino Acids 2011, 42:845-855.
50. Pérez-Álvarez M.J., Maza M.D.C., Anton M., Ordoñez L., Wandosell F. Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J Neuroinflamm 2012, 9:157.
51. Pike B.R., Flint J., Dutta S., Johnson E., Wang K.K., Hayes R.L. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 2001, 78:1297-1306.
52. Pike B.R., Flint J., Dave J.R., Lu X.-C.M., Wang K.K.K., Tortella F.C., Hayes R.L. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 2004, 24:98-106.
53. Reddy R.K., Mao C., Baumeister P., Austin R.C., Kaufman R.J., Lee A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003, 278:20915-20924.
54. Rich P.R., Mischis L.A., Purton S., Wiskich J.T. The sites of interaction of triphenyltetrazolium chloride with mitochondrial respiratory chains. FEMS Microbiol Lett 2001, 202:181-187.
55. Schäbitz W.R., Li F., Irie K., Sandage B.W., Locke K.W., Fisher M. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke 1999, 30:427-431. [discussion 431-432].
56. Schäbitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counter regulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 2000, 31:2212-2217.
57. Schäbitz W.R., Hoffmann T.T., Heiland S., Kollmar R., Bardutzky J., Sommer C., Schwab S. Delayed neuroprotective effect of insulin-like growth factor-I after experimental transient focal cerebral ischemia monitored with MRI. Stroke 2001, 32:1226-1233.
58. Shibata M., Hattori H., Sasaki T., Gotoh J., Hamada J., Fukuuchi Y. Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience 2003, 118:491-499.
59. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
60. Solaroglu I., Tsubokawa T., Cahill J., Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965-974.
61. Sun M., Xu C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol Neurobiol 2008, 28:593-611.
62. Sun M., Gu Y., Zhao Y., Xu C. Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats. Amino Acids 2011, 40:1419-1429.
63. Sun M., Zhao Y.-M., Gu Y., Xu C. Therapeutic window of taurine against experimental stroke in rats. Transl Res 2012, 160:223-229.
64. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990, 10:290-293.
65. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006, 7:880-885.
66. Taranukhin A.G., Taranukhina E.Y., Saransaari P., Djatchkova I.M., Pelto-Huikko M., Oja S.S. Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei. Amino Acids 2008, 34:169-174.
67. Turner R.J., Vink R. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats. Neuroscience 2012, 220:1-10.
68. Venna V.R., Li J., Hammond M.D., Mancini N.S., McCullough L.D. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. Eur J Neurosci 2014, 39:2129-2138.
69. Wang C.-C., Chio C.-C., Chang C.-H., Kuo J.-R., Chang C.-P. Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. BMC Pharmacol 2010, 10:11.
70. Wu J.-Y., Wu H., Jin Y., Wei J., Sha D., Prentice H., Lee H.-H., Lin C.-H., Lee Y.-H., Yang L.-L. Mechanism of neuroprotective function of taurine. Adv Exp Med Biol 2009, 643:169-179.
71. Xu L.-J., Ouyang Y.-B., Xiong X., Stary C.M., Giffard R.G. Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia. Exp Neurol 2015, 264:1-7.
72. Yano S., Tokumitsu H., Soderling T.R. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998, 396:584-587.
73. Yoshida H., Okada T., Haze K., Yanagi H., Yura T., Negishi M., Mori K. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol 2000, 20:6755-6767.
74. Yoshida H., Matsui T., Yamamoto A., Okada T., Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107:881-891.
75. Yung H., Korolchuk S., Tolkovsky A.M., Charnock-Jones D.S., Burton G.J. Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells. FASEB J 2007, 21:872-884.
76. Zeng K., Xu H., Mi M., Zhang Q., Zhang Y., Chen K., Chen F., Zhu J., Yu X. Dietary taurine supplementation prevents glial alterations in retina of diabetic rats. Neurochem Res 2009, 34:244-254.
77. Zhang C. Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia. Neurobiol Dis 2002, 10:289-305.
78. Zivin J.A. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol 2009, 66:6-10.